Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: An Anti-Parkinson's Disease Drug via Targeting Adenosine A2A Receptor Enhances Amyloid-β Generation and γ-Secretase Activity

  • The PLOS ONE Staff

Several of the grant numbers in the Funding section are listed incorrectly. The correct funding information is as follows: This research was supported by the Ministry of Science and Technology of China (2015CB964502, 2014CB964802), the National Natural Science Foundation of China (31371419), Science and Technology Commission of Shanghai Municipality (14DZ1900402). The publisher apologizes for the errors.

Reference

  1. 1. Lu J, Cui J, Li X, Wang X, Zhou Y, Yang W, et al. (2016) An Anti-Parkinson’s Disease Drug via Targeting Adenosine A2A Receptor Enhances Amyloid-β Generation and γ-Secretase Activity. PLoS ONE 11(11): e0166415. pmid:27835671

Citation: The PLOS ONE Staff (2017) Correction: An Anti-Parkinson's Disease Drug via Targeting Adenosine A2A Receptor Enhances Amyloid-β Generation and γ-Secretase Activity. PLoS ONE 12(2): e0172775. https://doi.org/10.1371/journal.pone.0172775

Published: February 16, 2017

Copyright: © 2017 The PLOS ONE Staff. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.